Berman & DeValerio & Pease Advises Investors Of Pending Class Actions.

Business/Technology Editors

BOSTON--(BUSINESS WIRE)--Sept. 22, 2000

Securities fraud class actions are pending against Acrodyne Communications, Inc., TenFold Corporation, DT Industries, Inc., Gliatech Inc., Mercator Software, Inc. and Thomas & Betts Corp., Berman DeValerio & Pease LLP said today.

If you purchased stock in any of these companies, you may be a member of the class and have until the dates specified below to move the court to become lead plaintiff. You may contact Berman DeValerio & Pease to learn more about your rights and interests in these cases and your ability to potentially recoup your losses, or you may hire counsel of your own choice.

ACRODYNE COMMUNICATIONS, INC. (NASDAQ: ACRO)

The complaint charges Acrodyne with issuing false and misleading financial statements that may require the company to restate its 1999 and first quarter 2000 financial statements. Investors who purchased Acrodyne securities between May 18, 1999 and August 14, 2000 may be part of the action. The lead plaintiff motion is required to be filed no later than October 16, 2000.

TENFOLD CORPORATION (NASDAQ: TENF)

TenFold is accused of failing to properly account for known problems with large customer orders. Right before Barron's published an article questioning the company's problems with many of its customers, TenFold's officers sold more than $26 million of their common stock. The complaint says the company recently acknowledged that it had overstated revenues and understated allowances for doubtful accounts. If you purchased TenFold stock between January 31, 2000 and August 14, 2000 you may be part of the class. Motions for lead plaintiff must be filed by October 16, 2000.

DT INDUSTRIES, INC. (NASDAQ: DTII)

According to the complaint, DTII and certain of its top officers issued materially false and misleading financial statements. On August 23, DTI disclosed that it was investigating possible accounting irregularities at its Kalish, Inc., subsidiary and that accounting "discrepancies" could impact previously reported annual and quarterly earnings for fiscal 1997, 1998 and 1999, and quarterly earnings for fiscal 2000. A Kalish senior financial officer was placed on administrative leave and DTII accepted the resignation of DTI's senior vice president of finance and administration. The company later said its investigation had extended to a second subsidiary. Investors who purchased DTII stock between September 29, 1997 and August 23, 2000 may be part of the action. The lead plaintiff motion must be filed no later than October 31, 2000.

GLIATECH INC. (NASDAQ: GLIA)

Gliatech is charged with securities law violations for failing to disclose adverse information about clinical trial results for its ADCON-L product. Gliatech announced on August 28 that the U.S. Food and Drug Administration had raised questions about clinical trial data the company had submitted to gain regulatory approval to market ADCON-L in the United States. The lawsuit alleges that Gliatech's prior public statements about ADCON-L were materially false and misleading. As a result, the complaint maintains, the price of Gliatech common stock was artificially inflated during the Class Period. Investors who purchased Gliatech stock between April 9, 1998 and August 29, 2000 may be part of the action. The lead plaintiff motion must be filed no later than November 6, 2000.

Mercator Software, Inc. (NASDAQ: MCTR)

The lawsuit accuses Mercator of improperly overstating its gross profits and net income while understating its operating expenses. On August 21, 2000, Mercator disclosed that it had restated and lowered first- and second-quarter 2000 earnings to account for approximately $2.4 million of underreported expenses. In addition, the company announced that it had accepted the resignation of its chief financial offer and fired its vice president of finance. Investors who purchased Mercator securities between April 20, 2000 and August 21, 2000 may be part of the action. The lead plaintiff motion must be filed no later than October 23, 2000.

Thomas & Betts Corporation (NYSE: TNB)

The complaint alleges that Thomas & Betts issued false financial statements for 1999 and the first quarter 2000, requiring a restatement of 1999 financial statements and possibly of financial statements for the first quarter of 2000. The lawsuit also accuses T&B of taking charges of $223.9 million during the second quarter of 2000 to increase reserves for accounts receivable, increase reserves for excess and obsolete inventory, reduce the carrying value of inventory and reverse revenue that should have been recorded as consignment sales. The company's stock lost more than 30% of its value on the news. Investors who purchased T&B stock between February 15, 2000 and August 21, 2000 may be part of the action. The lead plaintiff motion must be filed no later than October 27, 2000.

With offices in Boston and San Francisco, Berman DeValerio & Pease LLP has prosecuted shareholder class actions since 1982, recovering more than $1 billion for investors. The firm has acted as lead counsel in numerous lawsuits in which its clients accused companies of violating federal securities laws. It has successfully litigated these actions, and has been singled out for its excellence by the courts. The firm prides itself on its responsiveness to shareholders and their needs in each case.

If you are an investor in any of the companies listed above, or have any questions about any of these securities class actions, please contact the firm at [phone]. To be participant in any of these class actions, you need not take any action at this time. If you do have questions, please call us and ask to speak to one of the attorneys handling the case you are seeking information about or ask for Jeffrey C. Block, Esq. or Michael G. Lange, Esq. You can also write the firm at One Liberty Square, Boston, MA 02109, send us a facsimile at [phone] or send us an e-mail at [e-mail].

To learn more about any of these cases, or class actions in general, visit the firm's website at www.bermanesq.com.